Global Biopolar Disorder Therapeutics Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

  • receipt Report ID : 146747
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 137
  • list Pharmaceuticals and Healthcare

Bipolar disorder, also known as manic depression, is a mental disorder that could lead to periods of depression and elevated mood. The treatment of bipolar disorder includes psychotherapy as well as medications such as mood stabilizers and antipsychotics.

Scope of the Report:

This report focuses on the Biopolar Disorder Therapeutics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Rise in prevalence of bipolar disorder, high unmet medical needs, technological advancement and government initiatives are the key factors accelerating the growth of the bipolar disorder therapeutics market. Increase in investment in research and development and collaboration activities between companies for product development are the other factors likely to propel the bipolar disorder therapeutics market. Additionally, the rise in awareness about the disorder has led to increased understanding among the public. This has led to a rise in the number of individuals seeking medical attention for the treatment of the disorder. Also, strategic alliances formed between vendors help in increased penetration of the drugs in the market and increase market share. However, stringent regulations act as a major restraint of the bipolar disorder therapeutics market. North America dominates the global bipolar disorder therapeutics market due to new product innovation, increased awareness among people about bipolar disease, and rise in prevalence of bipolar disorders.

The worldwide market for Biopolar Disorder Therapeutics is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

Allergan

AstraZeneca

Eli Lilly

GlaxoSmithKline

Janssen Pharmaceuticals

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Mood Stabilizers

Antipsychotic Drugs

Antidepressant Drugs

Others

Market Segment by Applications, can be divided into

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

There are 15 Chapters to deeply display the global Biopolar Disorder Therapeutics market.

Chapter 1, to describe Biopolar Disorder Therapeutics Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Biopolar Disorder Therapeutics, with sales, revenue, and price of Biopolar Disorder Therapeutics, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Biopolar Disorder Therapeutics, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Biopolar Disorder Therapeutics market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Biopolar Disorder Therapeutics sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Biopolar Disorder Therapeutics Introduction

1.2 Market Analysis by Type

1.2.1 Mood Stabilizers

1.2.2 Antipsychotic Drugs

1.2.3 Antidepressant Drugs

1.2.4 Others

1.3 Market Analysis by Applications

1.3.1 Hospital Pharmacies

1.3.2 Retail Pharmacies

1.3.3 Online Pharmacies

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Allergan

2.1.1 Business Overview

2.1.2 Biopolar Disorder Therapeutics Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Allergan Biopolar Disorder Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 AstraZeneca

2.2.1 Business Overview

2.2.2 Biopolar Disorder Therapeutics Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 AstraZeneca Biopolar Disorder Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Eli Lilly

2.3.1 Business Overview

2.3.2 Biopolar Disorder Therapeutics Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Eli Lilly Biopolar Disorder Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 GlaxoSmithKline

2.4.1 Business Overview

2.4.2 Biopolar Disorder Therapeutics Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 GlaxoSmithKline Biopolar Disorder Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Janssen Pharmaceuticals

2.5.1 Business Overview

2.5.2 Biopolar Disorder Therapeutics Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Janssen Pharmaceuticals Biopolar Disorder Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Biopolar Disorder Therapeutics Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Biopolar Disorder Therapeutics Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Biopolar Disorder Therapeutics Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Biopolar Disorder Therapeutics Manufacturer Market Share in 2017

3.3.2 Top 6 Biopolar Disorder Therapeutics Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Biopolar Disorder Therapeutics Market Analysis by Regions

4.1 Global Biopolar Disorder Therapeutics Sales, Revenue and Market Share by Regions

4.1.1 Global Biopolar Disorder Therapeutics Sales and Market Share by Regions (2013-2018)

4.1.2 Global Biopolar Disorder Therapeutics Revenue and Market Share by Regions (2013-2018)

4.2 North America Biopolar Disorder Therapeutics Sales and Growth Rate (2013-2018)

4.3 Europe Biopolar Disorder Therapeutics Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Biopolar Disorder Therapeutics Sales and Growth Rate (2013-2018)

4.5 South America Biopolar Disorder Therapeutics Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Biopolar Disorder Therapeutics Sales and Growth Rate (2013-2018)

5 North America Biopolar Disorder Therapeutics by Countries

5.1 North America Biopolar Disorder Therapeutics Sales, Revenue and Market Share by Countries

5.1.1 North America Biopolar Disorder Therapeutics Sales and Market Share by Countries (2013-2018)

5.1.2 North America Biopolar Disorder Therapeutics Revenue and Market Share by Countries (2013-2018)

5.2 United States Biopolar Disorder Therapeutics Sales and Growth Rate (2013-2018)

5.3 Canada Biopolar Disorder Therapeutics Sales and Growth Rate (2013-2018)

5.4 Mexico Biopolar Disorder Therapeutics Sales and Growth Rate (2013-2018)

6 Europe Biopolar Disorder Therapeutics by Countries

6.1 Europe Biopolar Disorder Therapeutics Sales, Revenue and Market Share by Countries

6.1.1 Europe Biopolar Disorder Therapeutics Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Biopolar Disorder Therapeutics Revenue and Market Share by Countries (2013-2018)

6.2 Germany Biopolar Disorder Therapeutics Sales and Growth Rate (2013-2018)

6.3 UK Biopolar Disorder Therapeutics Sales and Growth Rate (2013-2018)

6.4 France Biopolar Disorder Therapeutics Sales and Growth Rate (2013-2018)

6.5 Russia Biopolar Disorder Therapeutics Sales and Growth Rate (2013-2018)

6.6 Italy Biopolar Disorder Therapeutics Sales and Growth Rate (2013-2018)

7 Asia-Pacific Biopolar Disorder Therapeutics by Countries

7.1 Asia-Pacific Biopolar Disorder Therapeutics Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Biopolar Disorder Therapeutics Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Biopolar Disorder Therapeutics Revenue and Market Share by Countries (2013-2018)

7.2 China Biopolar Disorder Therapeutics Sales and Growth Rate (2013-2018)

7.3 Japan Biopolar Disorder Therapeutics Sales and Growth Rate (2013-2018)

7.4 Korea Biopolar Disorder Therapeutics Sales and Growth Rate (2013-2018)

7.5 India Biopolar Disorder Therapeutics Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Biopolar Disorder Therapeutics Sales and Growth Rate (2013-2018)

8 South America Biopolar Disorder Therapeutics by Countries

8.1 South America Biopolar Disorder Therapeutics Sales, Revenue and Market Share by Countries

8.1.1 South America Biopolar Disorder Therapeutics Sales and Market Share by Countries (2013-2018)

8.1.2 South America Biopolar Disorder Therapeutics Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Biopolar Disorder Therapeutics Sales and Growth Rate (2013-2018)

8.3 Argentina Biopolar Disorder Therapeutics Sales and Growth Rate (2013-2018)

8.4 Colombia Biopolar Disorder Therapeutics Sales and Growth Rate (2013-2018)

9 Middle East and Africa Biopolar Disorder Therapeutics by Countries

9.1 Middle East and Africa Biopolar Disorder Therapeutics Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Biopolar Disorder Therapeutics Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Biopolar Disorder Therapeutics Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Biopolar Disorder Therapeutics Sales and Growth Rate (2013-2018)

9.3 UAE Biopolar Disorder Therapeutics Sales and Growth Rate (2013-2018)

9.4 Egypt Biopolar Disorder Therapeutics Sales and Growth Rate (2013-2018)

9.5 Nigeria Biopolar Disorder Therapeutics Sales and Growth Rate (2013-2018)

9.6 South Africa Biopolar Disorder Therapeutics Sales and Growth Rate (2013-2018)

10 Global Biopolar Disorder Therapeutics Market Segment by Type

10.1 Global Biopolar Disorder Therapeutics Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Biopolar Disorder Therapeutics Sales and Market Share by Type (2013-2018)

10.1.2 Global Biopolar Disorder Therapeutics Revenue and Market Share by Type (2013-2018)

10.2 Mood Stabilizers Sales Growth and Price

10.2.1 Global Mood Stabilizers Sales Growth (2013-2018)

10.2.2 Global Mood Stabilizers Price (2013-2018)

10.3 Antipsychotic Drugs Sales Growth and Price

10.3.1 Global Antipsychotic Drugs Sales Growth (2013-2018)

10.3.2 Global Antipsychotic Drugs Price (2013-2018)

10.4 Antidepressant Drugs Sales Growth and Price

10.4.1 Global Antidepressant Drugs Sales Growth (2013-2018)

10.4.2 Global Antidepressant Drugs Price (2013-2018)

10.5 Others Sales Growth and Price

10.5.1 Global Others Sales Growth (2013-2018)

10.5.2 Global Others Price (2013-2018)

11 Global Biopolar Disorder Therapeutics Market Segment by Application

11.1 Global Biopolar Disorder Therapeutics Sales Market Share by Application (2013-2018)

11.2 Hospital Pharmacies Sales Growth (2013-2018)

11.3 Retail Pharmacies Sales Growth (2013-2018)

11.4 Online Pharmacies Sales Growth (2013-2018)

12 Biopolar Disorder Therapeutics Market Forecast (2018-2023)

12.1 Global Biopolar Disorder Therapeutics Sales, Revenue and Growth Rate (2018-2023)

12.2 Biopolar Disorder Therapeutics Market Forecast by Regions (2018-2023)

12.2.1 North America Biopolar Disorder Therapeutics Market Forecast (2018-2023)

12.2.2 Europe Biopolar Disorder Therapeutics Market Forecast (2018-2023)

12.2.3 Asia-Pacific Biopolar Disorder Therapeutics Market Forecast (2018-2023)

12.2.4 South America Biopolar Disorder Therapeutics Market Forecast (2018-2023)

12.2.5 Middle East and Africa Biopolar Disorder Therapeutics Market Forecast (2018-2023)

12.3 Biopolar Disorder Therapeutics Market Forecast by Type (2018-2023)

12.3.1 Global Biopolar Disorder Therapeutics Sales Forecast by Type (2018-2023)

12.3.2 Global Biopolar Disorder Therapeutics Market Share Forecast by Type (2018-2023)

12.4 Biopolar Disorder Therapeutics Market Forecast by Application (2018-2023)

12.4.1 Global Biopolar Disorder Therapeutics Sales Forecast by Application (2018-2023)

12.4.2 Global Biopolar Disorder Therapeutics Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Biopolar Disorder Therapeutics Picture

Table Product Specifications of Biopolar Disorder Therapeutics

Figure Global Sales Market Share of Biopolar Disorder Therapeut

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery